Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Completion of investment by Life Biosciences LLC and capital raising update

April 8, 2019 Kerry Rowe

Completion of investment by Life Biosciences LLC and capital raising update

Post navigation

Results of General Meeting

Change of Company Name

Related Posts

Prana Biotechnology announces top line results of Phase 2 IMAGINE trial of PBT2 in Alzheimer’s disease

March 31, 2014

Link to XBRL Interactive Data 30 June 2018

September 3, 2018

PBT434 drug candidate shows potential as “next-generation” disease-modifying treatment in Parkinson’s Disease

July 17, 2013

Recent Posts

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
Alterity receives a $4.8 million R&D Tax Incentive Refund
European Commission approves Orphan Designation for Alterity’s lead drug candidate
Chairman’s Address to Shareholders 2019 Annual General Meeting
AGM 2019 Presentation

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065